# Marketing Campaign Analysis Plan
## Measuring Causal Impact and Investment Recommendations

**Prepared for:** Marketing Director  
**Date:** 2024  
**Objective:** Evaluate the causal impact of Q2-Q3 2024 marketing campaigns and provide data-driven recommendations for next quarter's investment strategy

---

## Executive Summary

We analyzed four marketing campaigns conducted in 2024 using appropriate causal inference methods matched to each campaign's design. Our findings:

| Campaign | Method | Estimated Effect | Confidence | Recommendation |
|----------|--------|------------------|------------|----------------|
| **C001: Spring Email Blast** | A/B Test | **+$4.44/user/month** | ✅ High | **SCALE UP** |
| **C002: Premium Upsell Push** | Regression Adjusted | **+$2.87/user/month** | ⚠️ Medium | Redesign with proper control |
| **C003: West Coast Regional** | Difference-in-Differences | **+$3.11/user/month** | ✅ High | **EXPAND NATIONALLY** |
| **C004: Win-Back Campaign** | A/B Test | **+10.8% reactivation** | ✅ High | **CONTINUE & OPTIMIZE** |

**Key Insight:** Campaigns C001, C003, and C004 show strong, statistically significant positive effects with high confidence. C002 shows promise but requires better experimental design to measure true impact.

---

## Campaign 1: Spring Email Blast (C001)

### Campaign Overview
- **Channel:** Email
- **Period:** April 1-30, 2024
- **Target:** All active users
- **Assignment:** Randomized (50% treatment, 50% control)
- **Sample Size:** 710 users (359 exposed, 351 control)
- **Intended Outcome:** Increase monthly spending

### Data Type: Experimental (Randomized Controlled Trial)

This is a **gold standard A/B test** with random assignment. Users were randomly assigned to receive the email campaign or not, creating comparable treatment and control groups.

### Analytical Method: Standard A/B Test Analysis

**Why this method?**
- Random assignment ensures treatment and control groups are statistically equivalent
- Any differences in outcomes can be attributed to the campaign (causal effect)
- Simple comparison of means provides unbiased estimate

**Analysis Approach:**
1. Compare average outcomes between exposed and control groups
2. Calculate Average Treatment Effect (ATE)
3. Test statistical significance using t-test
4. Check randomization balance (pre-campaign values should be similar)

### Results

**Balance Check:** ✅ PASSED
- Pre-campaign spending difference: -$0.03 (essentially zero)
- This confirms successful randomization

**Treatment Effect:**
- **Exposed group:** $28.11 → $32.86 (+$4.75)
- **Control group:** $28.14 → $28.45 (+$0.31)
- **Average Treatment Effect (ATE): +$4.44 per user per month**
- **Statistical significance:** p < 0.001 (highly significant)

**Interpretation:**
The email campaign caused a $4.44 increase in monthly spending per user. This is a true causal effect because:
1. Groups were comparable before the campaign (randomization worked)
2. The only difference was exposure to the campaign
3. The effect is statistically significant and unlikely due to chance

### Caveats and Limitations

1. **External Validity:** Results apply to "active users" in April 2024. May not generalize to:
   - Inactive users
   - Different time periods (seasonality)
   - Users who joined after April

2. **Short-term Effect:** We only observe one month post-campaign. Questions remain:
   - Does the effect persist over time?
   - Is this new spending or pulled forward from future months?

3. **Mechanism Unknown:** We know the campaign worked but not why:
   - Which email elements drove the effect?
   - What types of users responded most?

4. **Spillover Effects:** Assumes no contamination between groups (control users didn't see forwarded emails)

### Recommendation: ✅ SCALE UP

**Confidence Level:** HIGH

**Action Items:**
1. **Immediate:** Repeat this campaign monthly with similar active user segments
2. **Optimize:** Test variations to understand what drives the effect:
   - Subject line A/B tests
   - Content variations
   - Timing experiments
3. **Segment Analysis:** Identify which user segments respond best for targeted follow-ups
4. **Long-term Tracking:** Monitor users from this cohort for 3-6 months to assess persistence

**Expected ROI:** At $4.44/user/month, if email costs are <$0.50/user, ROI is ~800%

---

## Campaign 2: Premium Upsell Push (C002)

### Campaign Overview
- **Channel:** In-app messaging
- **Period:** June 1-30, 2024
- **Target:** High-spend users (monthly_spend > $80)
- **Assignment:** Targeted (not randomized)
- **Sample Size:** 144 users (72 exposed, 72 control)
- **Intended Outcome:** Increase monthly spending

### Data Type: Observational (Non-Randomized)

This is **NOT a randomized experiment**. Users were selected for treatment based on their spending behavior, creating a **selection bias problem**.

### Analytical Method: Regression with Baseline Controls

**Why this method?**
- Simple comparison would be biased because exposed users were already high spenders
- Need to control for baseline differences
- Regression adjustment can partially account for selection on observables

**Analysis Approach:**
1. Identify the selection bias (pre-campaign differences)
2. Use regression to control for baseline spending
3. Interpret coefficient on treatment indicator as adjusted effect
4. Acknowledge remaining limitations

### Results

**Balance Check:** ❌ FAILED
- Pre-campaign spending difference: **+$135.59**
- Exposed group averaged $200.35 vs. control at $64.77
- **This is a massive imbalance indicating selection bias**

**Naive Estimate (BIASED):**
- Exposed change: +$9.72
- Control change: -$0.04
- Naive difference: **+$9.76** ⚠️ DO NOT USE

**Regression-Adjusted Estimate:**
- After controlling for baseline spending: **+$2.87 per user per month**
- This accounts for the fact that high spenders naturally spend more
- Statistical significance: p < 0.001

**Interpretation:**
The naive estimate of $9.76 is severely biased upward. After controlling for baseline spending, the true effect is likely closer to $2.87. However, even this estimate has limitations (see below).

### Caveats and Limitations

1. **Selection Bias:** ⚠️ MAJOR CONCERN
   - "Control" group appears to be users who didn't meet targeting criteria
   - Not a true control group - they're fundamentally different users
   - Regression can only control for observed differences (baseline spending)
   - Unobserved differences may remain (e.g., engagement, product usage patterns)

2. **Confounding:** 
   - High spenders may have different growth trajectories regardless of campaign
   - May be more responsive to any marketing (not just this campaign)
   - Could have other concurrent exposures we don't observe

3. **Regression Assumptions:**
   - Assumes linear relationship between baseline and change
   - Assumes no interaction effects
   - May not fully capture complex selection patterns

4. **Limited Overlap:**
   - Few control users with spending levels similar to treated users
   - Makes matching/comparison difficult
   - Extrapolating from low spenders to high spenders is risky

### Recommendation: ⚠️ REDESIGN WITH PROPER EXPERIMENT

**Confidence Level:** MEDIUM-LOW (effect likely positive but magnitude uncertain)

**Action Items:**

1. **DO NOT scale based on current results** - the $9.76 estimate is unreliable

2. **Redesign as proper A/B test:**
   - Identify high-spend users (monthly_spend > $80)
   - **Randomly assign 50% to receive upsell, 50% to control**
   - This will give unbiased estimate of true effect

3. **Alternative: Regression Discontinuity Design**
   - If you must target based on spending threshold
   - Compare users just above vs. just below $80 threshold
   - Those near the threshold are more comparable

4. **Interim Action:**
   - The adjusted estimate of $2.87 suggests positive effect
   - Can continue campaign but with modest expectations
   - Prioritize running proper experiment to get true estimate

**Why This Matters:**
- Difference between $9.76 and $2.87 is $6.89 per user
- On 1,000 users, that's $6,890/month or $82,680/year
- Wrong estimate leads to wrong investment decisions

---

## Campaign 3: West Coast Regional Push (C003)

### Campaign Overview
- **Channel:** Mixed (email, in-app, social)
- **Period:** July 1 - August 31, 2024
- **Target:** West region users
- **Assignment:** Geographic rollout
- **Sample Size:** 1,000 users (274 West/exposed, 726 Other/control)
- **Intended Outcome:** Increase monthly spending

### Data Type: Quasi-Experimental (Geographic Natural Experiment)

This is a **geographic rollout** where treatment was determined by location, not random assignment. However, we can use other regions as a comparison group.

### Analytical Method: Difference-in-Differences (DiD)

**Why this method?**
- Geographic assignment means West and Other regions may differ systematically
- DiD controls for time-invariant regional differences
- Compares change in West to change in Other regions
- Removes bias from baseline regional differences

**Analysis Approach:**
1. Calculate change in West region (before vs. after campaign)
2. Calculate change in Other regions (same time period)
3. DiD estimate = (Change in West) - (Change in Other)
4. This removes regional baseline differences and common time trends

**Key Assumption:** Parallel trends
- Without the campaign, West and Other regions would have changed similarly
- We can partially test this with pre-campaign data if available

### Results

**Pre-Campaign Baseline:**
- West region: $31.47/user/month
- Other regions: $27.70/user/month
- Difference: +$3.77 (West already higher)

**Post-Campaign:**
- West region: $35.23/user/month (+$3.76 change)
- Other regions: $28.35/user/month (+$0.64 change)

**Difference-in-Differences Estimate:**
- **Treatment Effect: +$3.11 per user per month**
- Statistical significance: p < 0.001

**Interpretation:**
The West region increased spending by $3.76, but Other regions also increased by $0.64 (possibly due to seasonality or other factors). The campaign's causal effect is the difference: $3.11. This controls for:
- Baseline regional differences (West was already higher)
- Common time trends affecting all regions

### Caveats and Limitations

1. **Parallel Trends Assumption:** ⚠️ CRITICAL
   - Assumes West and Other regions would have trended similarly without campaign
   - Cannot directly test this with only 2 time periods
   - Violation would bias the estimate
   - **Mitigation:** Pre-campaign baseline difference ($3.77) suggests regions may differ structurally

2. **Regional Differences:**
   - West region users may differ in ways beyond geography
   - Different demographics, product usage, or preferences
   - These could interact with time trends

3. **Spillover Effects:**
   - Users in Other regions might have seen campaign content (social media)
   - Would underestimate true effect
   - Mixed channel makes this more likely

4. **Concurrent Events:**
   - Other things may have happened in West region during July-August
   - Local events, competitors, economic conditions
   - Would confound the estimate

5. **Sample Size Imbalance:**
   - Only 274 West users vs. 726 Other
   - Less precision in treatment group estimate

### Recommendation: ✅ EXPAND NATIONALLY (with caution)

**Confidence Level:** HIGH (with noted caveats)

**Action Items:**

1. **Validate with Staggered Rollout:**
   - Don't launch nationally all at once
   - Roll out to one additional region (e.g., East Coast)
   - Use remaining regions as control
   - Repeat DiD analysis to confirm effect

2. **Test Parallel Trends:**
   - Analyze 2-3 months of pre-campaign data
   - Check if West and Other regions had similar trends before July
   - If trends were parallel, increases confidence in DiD estimate

3. **Segment Analysis:**
   - Break down by user characteristics within regions
   - Identify if effect varies by user type
   - Helps understand mechanism and optimize targeting

4. **Monitor for Spillover:**
   - Track social media reach in non-target regions
   - Survey users in Other regions about campaign awareness
   - Adjust estimate if significant spillover detected

5. **National Rollout Plan:**
   - If validation confirms effect, proceed with national expansion
   - Expected lift: $3.11 per user per month
   - On 10,000 users: $31,100/month or $373,200/year

**Why This Works:**
- Effect is substantial and statistically significant
- DiD method is appropriate for geographic rollout
- Can validate before full commitment
- Multiple channels provide redundancy

---

## Campaign 4: Win-Back Campaign (C004)

### Campaign Overview
- **Channel:** Email
- **Period:** September 1-30, 2024
- **Target:** Inactive users (60+ days no activity)
- **Assignment:** Randomized (50% treatment, 50% control)
- **Sample Size:** 290 users (147 exposed, 143 control)
- **Intended Outcome:** Reactivation (return to platform and spend)

### Data Type: Experimental (Randomized Controlled Trial)

This is another **gold standard A/B test** with random assignment among inactive users.

### Analytical Method: Standard A/B Test Analysis

**Why this method?**
- Random assignment ensures comparable groups
- Simple comparison provides unbiased causal estimate
- Can analyze both reactivation rate and spending outcomes

**Analysis Approach:**
1. Compare reactivation rates (% with post-campaign spending > 0)
2. Compare average spending changes
3. Test statistical significance
4. Check randomization balance

### Results

**Balance Check:** ✅ PASSED
- Pre-campaign spending: $0.00 for both groups (all inactive)
- Perfect balance as expected for inactive users

**Reactivation Rates:**
- **Exposed group: 15.6% reactivated (23/147 users)**
- **Control group: 4.9% reactivated (7/143 users)**
- **Lift: +10.8 percentage points**
- **Relative increase: 220% (more than 3x the control rate)**

**Spending Impact:**
- Exposed group change: +$0.16/user
- Control group change: +$0.05/user
- **Average Treatment Effect: +$0.11 per user**
- Statistical significance: p = 0.003

**Interpretation:**
The win-back campaign successfully reactivated inactive users:
1. Reactivation rate increased from 4.9% to 15.6% (10.8 point lift)
2. Average spending increased by $0.11 per user in the exposed group
3. Both effects are statistically significant and causally attributable to the campaign

### Caveats and Limitations

1. **Small Absolute Spending:**
   - Effect is $0.11/user/month - seems small
   - But baseline is $0, so this is infinite % increase
   - More meaningful to focus on reactivation rate

2. **Short-term Measurement:**
   - Only one month post-campaign
   - Key questions:
     - Do reactivated users stay active?
     - Does spending grow over time?
     - What's the lifetime value of reactivated users?

3. **Sample Size:**
   - 290 users is smaller than other campaigns
   - Limits ability to analyze subgroups
   - Less precision in estimates

4. **Definition of Inactive:**
   - "60+ days no activity" is somewhat arbitrary
   - Effect may vary for different inactivity lengths
   - Very long-term inactive users may be harder to reactivate

5. **Reactivation Quality:**
   - Some reactivated users spent very little
   - Need to distinguish meaningful reactivation from one-time returns
   - Long-term retention is the real goal

### Recommendation: ✅ CONTINUE & OPTIMIZE

**Confidence Level:** HIGH

**Action Items:**

1. **Immediate Continuation:**
   - 10.8 percentage point lift in reactivation is substantial
   - Continue monthly win-back campaigns for inactive users
   - Even at $0.11/user, positive ROI if email costs < $0.05/user

2. **Optimize Targeting:**
   - Segment by inactivity length (60-90 days, 90-180 days, 180+ days)
   - Test different messages for different segments
   - May find higher response rates in recently inactive users

3. **Long-term Tracking:**
   - **CRITICAL:** Track reactivated users for 6-12 months
   - Measure:
     - Retention rate (% still active after 3, 6, 12 months)
     - Spending trajectory over time
     - Lifetime value compared to acquisition cost
   - This will determine true campaign value

4. **Content Optimization:**
   - Test different email approaches:
     - Discount/incentive offers
     - New feature announcements
     - "We miss you" emotional appeals
     - Personalized recommendations
   - Run A/B tests within the exposed group

5. **Expand Definition:**
   - Test campaigns for users inactive 30-60 days (earlier intervention)
   - May prevent churn before it becomes entrenched
   - Compare cost-effectiveness of prevention vs. reactivation

6. **Calculate True ROI:**
   - Current: $0.11/user/month immediate effect
   - If 50% of reactivated users stay active for 6 months at $5/month average:
     - 15.6% × 50% × $5 × 6 = $2.34 lifetime value per targeted user
   - Need to track actual retention to validate

**Why This Matters:**
- Reactivation is typically cheaper than new acquisition
- 10.8% lift is meaningful for reducing churn
- Even small spending increases compound over time
- Builds foundation for ongoing retention strategy

---

## Cross-Campaign Insights and Recommendations

### Methodological Summary

Our analysis demonstrates the importance of matching analytical methods to campaign design:

| Design Type | Method | Campaigns | Confidence |
|-------------|--------|-----------|------------|
| Randomized Experiment | A/B Test | C001, C004 | ✅ High |
| Geographic Rollout | Difference-in-Differences | C003 | ✅ High |
| Targeted (Non-Random) | Regression Adjustment | C002 | ⚠️ Medium-Low |

**Key Lesson:** Randomization is the gold standard. When not possible, quasi-experimental methods (DiD) can work, but require careful assumptions. Purely observational designs (C002) are problematic.

### Investment Priorities for Next Quarter

**Tier 1: High Confidence, High Impact - SCALE IMMEDIATELY**

1. **Spring Email Blast (C001):** +$4.44/user/month
   - Repeat monthly with active user base
   - Budget: Allocate for 100% of active users
   - Expected return: ~$4/user after costs

2. **West Coast Regional (C003):** +$3.11/user/month
   - Expand to additional regions with staggered rollout
   - Validate effect, then go national
   - Expected return: ~$3/user after costs

**Tier 2: Proven Concept, Optimize - CONTINUE WITH IMPROVEMENTS**

3. **Win-Back Campaign (C004):** +10.8% reactivation
   - Continue monthly for inactive users
   - Invest in content optimization and segmentation
   - Track long-term retention to validate LTV

**Tier 3: Promising but Uncertain - REDESIGN BEFORE SCALING**

4. **Premium Upsell (C002):** +$2.87/user/month (adjusted)
   - DO NOT scale based on current results
   - Redesign as proper randomized experiment
   - Then reassess based on unbiased estimate

### Budget Allocation Recommendation

Assuming $100,000 marketing budget for next quarter:

- **40% ($40,000):** Scale C001 (Spring Email) to all active users monthly
- **30% ($30,000):** Expand C003 (Regional) to 2-3 additional regions
- **15% ($15,000):** Continue and optimize C004 (Win-Back)
- **10% ($10,000):** Redesign and test C002 (Premium Upsell) properly
- **5% ($5,000):** Analytics and experimentation infrastructure

### Improving Future Campaign Measurement

**Best Practices Going Forward:**

1. **Default to Randomization:**
   - Always randomize when possible
   - Even for "targeted" campaigns, randomize within the target segment
   - Provides cleanest causal estimates

2. **Pre-Register Analysis Plans:**
   - Decide on metrics and methods before launching
   - Prevents cherry-picking results
   - Increases credibility

3. **Collect More Pre-Campaign Data:**
   - Multiple time periods before campaign
   - Enables testing parallel trends assumption
   - Allows for more sophisticated methods

4. **Track Long-Term Outcomes:**
   - Don't stop at 1 month post-campaign
   - Monitor cohorts for 6-12 months
   - Measure retention, LTV, and persistence

5. **Invest in Experimentation Platform:**
   - Automated randomization
   - Real-time monitoring
   - Statistical power calculations
   - Reduces manual errors and speeds up learning

6. **Document Everything:**
   - Campaign design decisions
   - Targeting criteria
   - Assignment mechanisms
   - Enables proper analysis and learning

---

## Technical Appendix

### Statistical Methods Used

**A/B Test Analysis (C001, C004):**
- Comparison of means between randomly assigned groups
- Two-sample t-test for significance
- Balance checks on pre-campaign covariates
- Average Treatment Effect (ATE) = E[Y₁|T=1] - E[Y₀|T=0]

**Difference-in-Differences (C003):**
- DiD = (Y_West,Post - Y_West,Pre) - (Y_Other,Post - Y_Other,Pre)
- Controls for time-invariant regional differences
- Controls for common time trends
- Assumes parallel trends in absence of treatment

**Regression Adjustment (C002):**
- Linear regression: ΔY = β₀ + β₁·Treatment + β₂·Baseline + ε
- β₁ estimates treatment effect controlling for baseline
- Reduces bias from selection on observables
- Does not eliminate bias from unobservables

### Data Quality Notes

- **Missing Data:** 70 users (7%) missing monthly_spend in users table
- **Data Consistency:** All campaign assignments properly recorded
- **Sample Sizes:** Adequate for main effects, limited for subgroup analysis
- **Time Periods:** Clean separation between campaigns (no overlap)

### Assumptions and Limitations

**General Assumptions:**
1. Stable Unit Treatment Value Assumption (SUTVA): No spillover between users
2. No measurement error in outcomes
3. Campaign exposure accurately recorded
4. No concurrent confounding campaigns

**Specific Limitations:**
1. Short follow-up period (1 month post-campaign)
2. Limited demographic and behavioral covariates
3. Cannot analyze heterogeneous treatment effects in detail
4. External validity to future time periods uncertain

---

## Conclusion

This analysis demonstrates that **three of four campaigns (C001, C003, C004) show strong, statistically significant positive effects** with high confidence in causal interpretation. These should be scaled and continued.

**Campaign C002** shows promise but suffers from selection bias that makes the true effect uncertain. It requires redesign with proper randomization before scaling.

The key to successful campaign measurement is **matching the analytical method to the campaign design**. Randomized experiments provide the cleanest estimates, but quasi-experimental methods can work when randomization isn't feasible.

**Next quarter's strategy should prioritize:**
1. Scaling proven winners (C001, C003)
2. Optimizing and tracking long-term effects (C004)
3. Fixing measurement issues before scaling uncertain campaigns (C002)
4. Investing in experimentation infrastructure for better future measurement

---

**Questions or need additional analysis?** Contact the analytics team for:
- Subgroup analyses
- Long-term tracking setup
- Experimental design consultation
- ROI modeling with different assumptions
